Jeffrey Wood, MD
Orthopaedic Surgery · Sugar Land, TXNPI 1356339832
Payments from drug & device makers
Across 108 payments — averaging $286.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$28K
- Medline Industries LP$1K
- Medtronic$415
- Abbott$176
- Penumbra, Inc.$171
- Boston Scientific$167
- plus $738 from 12 others
What the payments were for
- Consulting fees$23,95077%
- Travel & lodging$2,96410%
- Food & beverage$4,03213%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 75 | $28,187 |
| Medline Industries LP | 5 | $1,104 |
| Medtronic(2 entities) | 5 | $415 |
| Abbott | 4 | $176 |
| Penumbra, Inc. | 1 | $171 |
| Boston Scientific | 1 | $167 |
| Baxter Healthcare | 2 | $152 |
| Medinc Of Texas | 1 | $136 |
| Cook Medical LLC | 1 | $126 |
| Si-bone, Inc. | 1 | $93 |
| Centinel Spine, LLC | 2 | $50 |
| Ossur Americas, Inc. | 3 | $49 |
| Alafair Biosciences, Inc. | 2 | $32 |
| Alphatec Spine, Inc | 1 | $28 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
| Spineology Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NIAGARA LATERAL ACCESS SYSTEM$15,500
- CASCADIA INTERBODY SYSTEM$13,500
- OZARK CERVICAL PLATE SYSTEM$7,800
- YUKON OCT SPINAL SYSTEM$4,550
- EVEREST SPINAL SYSTEM$2,182
- Indigo System$171
- EKOSONIC$167
- RESTORE$150
- PREVELEAK$135
- MAZOR X SYSTEM$130
- Tornado$126
How this compares
$30,958 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 93 | $4,669 |
| Gabapentin | 345 | $2,531 |
| Pregabalin | 39 | $764 |
| Meloxicam | 237 | $746 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $370 |
| Methylprednisolone | 25 | $154 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $110 |
| Diclofenac Sodium | 12 | $98 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sugar Land
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- J Richard EvansonPlano$8.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Howard HarrisBedford$4.6M
- Tiffany HuynhHouston$4.6M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.